ConductScience.org, home

Paper39338555

Diversification of Pseudomonas aeruginosa Biofilm Populations under Repeated Phage Exposures Decreases the Efficacy of the Treatment.

Martinet MG and 7 others. Microorganisms, 2024. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Diversification of Pseudomonas aeruginosa Biofilm Populations under Repeated Phage Exposures Decreases the Efficacy of the Treatment. Papers, record 39338555. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39338555

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diversification of Pseudomonas aeruginosa Biofilm Populations under Repeated Phage Exposures Decreases the Efficacy of the Treatment.
PubMed
Journal
Microorganisms
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.39, provisional
iCite
Revised in PubMed
2024-09-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
861323Marie Skłodowska-Curie grantPubMed
13N15720Federal Ministry of Education and ResearchPubMed
19-10-0406Aase og Ejnar Danielsens FondPubMed

Source PubMed

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133,033,258CryoEM structure of the type IVa pilus secretin required for natural competence in Vibrio cholerae.Nat Commun2020https://conductscience.org/library/papers/33033258PubMed
236,073,942Surface-Induced cAMP Signaling Requires Multiple Features of the Pseudomonas aeruginosa Type IV Pili.J Bacteriol2022https://conductscience.org/library/papers/36073942PubMed
328,804,481The Type VI Secretion System: A Dynamic System for Bacterial Communication?Front Microbiol2017https://conductscience.org/library/papers/28804481PubMed
410,481,091The Pseudomonas aeruginosa algC gene product participates in rhamnolipid biosynthesis.FEMS Microbiol Lett1999https://conductscience.org/library/papers/10481091PubMed
535,240,424An overview of the current state of phage therapy for the treatment of biofilm-related infections.Curr Opin Virol2022https://conductscience.org/library/papers/35240424PubMed
635,620,437Genomic characterization of lytic bacteriophages targeting genetically diverse Pseudomonas aeruginosa clinical isolates.iScience2022https://conductscience.org/library/papers/35620437PubMed
730,821,815P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination.Pathog Dis2019https://conductscience.org/library/papers/30821815PubMed
834,578,219Oxidative Stress Response in Pseudomonas aeruginosa.Pathogens2021https://conductscience.org/library/papers/34578219PubMed
918,776,008PilF is an outer membrane lipoprotein required for multimerization and localization of the Pseudomonas aeruginosa Type IV pilus secretin.J Bacteriol2008https://conductscience.org/library/papers/18776008PubMed
1030,042,200The Pseudomonas aeruginosa PilSR Two-Component System Regulates Both Twitching and Swimming Motilities.mBio2018https://conductscience.org/library/papers/30042200PubMed
1130,496,396The Pseudomonas aeruginosa Pan-Genome Provides New Insights on Its Population Structure, Horizontal Gene Transfer, and Pathogenicity.Genome Biol Evol2019https://conductscience.org/library/papers/30496396PubMed
1223,597,188Formation of biofilms under phage predation: considerations concerning a biofilm increase.Biofouling2013https://conductscience.org/library/papers/23597188PubMed
1318,719,125Endogenous oxidative stress produces diversity and adaptability in biofilm communities.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18719125PubMed
1425,808,785Biogenesis of Pseudomonas aeruginosa type IV pili and regulation of their function.Environ Microbiol2015https://conductscience.org/library/papers/25808785PubMed
1515,883,588Stochasticity in gene expression: from theories to phenotypes.Nat Rev Genet2005https://conductscience.org/library/papers/15883588PubMed
1636,807,464Strain-specific quorum-sensing responses determine virulence properties in Vibrio anguillarum.Environ Microbiol2023https://conductscience.org/library/papers/36807464PubMed
1736,312,971Pseudomonas aeruginosa reference strains PAO1 and PA14: A genomic, phenotypic, and therapeutic review.Front Microbiol2022https://conductscience.org/library/papers/36312971PubMed
1833,374,637Pseudouridines of tRNA Anticodon Stem-Loop Have Unexpected Role in Mutagenesis in Pseudomonas sp.Microorganisms2020https://conductscience.org/library/papers/33374637PubMed
1934,372,538Emerging Phage Resistance in Pseudomonas aeruginosa PAO1 Is Accompanied by an Enhanced Heterogeneity and Reduced Virulence.Viruses2021https://conductscience.org/library/papers/34372538PubMed
204,632,251Mucoid variation in Pseudomonas aeruginosa induced by the action of phage.J Med Microbiol1973https://conductscience.org/library/papers/4632251PubMed

See all 57 references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42,943,529From Antagonism to Coevolutionary Regulation: Multidimensional Phage-Biofilm Interaction Networks and Translational Targeted Anti-Infection Strategies.Microorganisms2026https://conductscience.org/library/papers/42943529PubMed
42,690,138Phage vB_KpnM_NB cocktail synergizing with amikacin in inhibiting persister cells of Klebsiella pneumoniae.Appl Environ Microbiol2026https://conductscience.org/library/papers/42690138PubMed
42,058,179Spot-on phage therapy: stable formulations, smarter dosing for topical phage application.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42058179PubMed
41,900,873Bacteriophages as Therapeutic Agents for Pulmonary Infections: From Biological Principles to Clinical Applications.Pharmaceutics2026https://conductscience.org/library/papers/41900873PubMed
41,852,278Stepwise phage resistance and collateral phage susceptibility in Klebsiella pneumoniae.Emerg Microbes Infect2026https://conductscience.org/library/papers/41852278PubMed
41,399,705Temperate bacteriophage induced in Pseudomonas aeruginosa biofilms can modulate bacteriophage and antibiotic resistance.Biofilm2025https://conductscience.org/library/papers/41399705PubMed
40,165,964Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria.Front Immunol2025https://conductscience.org/library/papers/40165964PubMed
40,066,272The landscape of biofilm models for phage therapy: mimicking biofilms in diabetic foot ulcers using 3D models.Front Microbiol2025https://conductscience.org/library/papers/40066272PubMed
39,597,505Pseudomonas aeruginosa in the Frontline of the Greatest Challenge of Biofilm Infection-Its Tolerance to Antibiotics.Microorganisms2024https://conductscience.org/library/papers/39597505PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39338555

GET https://conductscience.org/api/papers/v1/39338555/references?page=2